In 2016, the FDA identified particulate matter contamination as the second leading cause of product recalls. Current contaminant detection techniques, such as light obscuration (LO), are restricted in ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
This past spring, the U.S. Pharmacopeia indicated that it was considering new guidelines for the determination of particulate matter in therapeutic formulations. Existing guidelines emphasize the use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback